Dr Margaret Delaney, MD in Berwyn Heights, MD - Pediatrics

Dr Margaret Delaney, MD is a Pediatrics physician based in Berwyn Heights, Maryland. Dr Margaret Delaney is licensed to practice in Maryland (license number D0036553) and her current practice location is 6201 Greenbelt Rd, L1-3, Berwyn Heights, Maryland. She can be reached at her office (for appointments etc.) via phone at (301) 345-1900.

NPI number for Dr Margaret Delaney is 1821143157 and her current mailing address is 6201 Greenbelt Road, L1-3, College Park, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1821143157.

Contact Information

	Dr Margaret Delaney, MD
	6201 Greenbelt Rd, L1-3, Berwyn Heights, MD 20740-2354
	(301) 345-1900
	(301) 345-7149

Physician's Profile

Full Name	Dr Margaret Delaney
Gender	Female
Speciality	Pediatrics
Location	6201 Greenbelt Rd, Berwyn Heights, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1821143157
Provider Enumeration Date: 01/25/2007
Last Update Date: 02/07/2012

Medical Identifiers

Medical identifiers for Dr Margaret Delaney such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821143157	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	D0036553 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Margaret Delaney is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Margaret Delaney, MD 6201 Greenbelt Road, L1-3, College Park, MD 20740 Ph: (301) 345-1900	Dr Margaret Delaney, MD 6201 Greenbelt Rd, L1-3, Berwyn Heights, MD 20740-2354 Ph: (301) 345-1900

News Archive

People with problems in the upper GI tract may be vulnerable to COVID-19 infection

No evidence so far indicates that food or drinks can transmit the virus that causes COVID-19, but new research at Washington University School of Medicine in St. Louis suggests that people with problems in the upper gastrointestinal (GI) tract may be vulnerable to infection after swallowing the virus.

IV connectors can play a crucial role in protecting patients from infections and other complications

Medical devices known as IV connectors, through which intravenous medication and nutrition are provided to a patient, can play a crucial role in protecting patients from life-threatening infections and other complications. But some types of connectors are much more prone to dangerous complications, according to a recent poster presentation at an international meeting of oncology nurses, the 17th International Conference on Cancer Nursing, held Sept. 9-13 in Prague, Czech Republic.

Novartis delivers 100 million child-friendly antimalarial treatments to 39 countries

One hundred million treatments of Coartem- Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announced today.

Women discuss intersection of sustainability, environment and empowerment, reproductive health at Rio+20 side event

In this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Vicky Markham, founding director of the Center for Environment and Population (CEP), summarizes a Rio+20 side event that took place on Thursday, titled "Rio+20 and Women's Lives: A Cross-General Dialogue."

Regeneron Pharmaceuticals provides update on REGN727, REGN475 antibody product candidates

Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.

Pediatrics Doctors in Berwyn Heights, MD

Dr. James Burgin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6201 Greenbelt Rd, L1-3, Berwyn Heights, MD 20740 Phone: 301-345-2270 Fax: 301-345-7149
Dr. Melvin Feldman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6201 Greenbelt Rd, L1-3, Berwyn Heights, MD 20740 Phone: 301-345-1900 Fax: 301-345-7149
Dr. Tsega Demmeke, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6201 Greenbelt Rd, Suite L 1, Berwyn Heights, MD 20740 Phone: 301-345-1900 Fax: 301-345-7149
Chuntung Changchien, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8824 Cunningham Dr Ste E, Berwyn Heights, MD 20740 Phone: 301-345-5311 Fax: 301-982-5065

Dr Margaret Delaney, MD - Pediatrics in Berwyn Heights, MD